Skip to main content
Log in

Incidence of local in-brain progression after supramarginal resection of cerebral metastases

  • Clinical Article - Brain Tumors
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Abstract

Background

Microsurgical circumferential stripping of intracerebral metastases is often insufficient in achieving local tumor control. Supramarginal resection may improve local tumor control.

Methods

A retrospective analysis was performed for patients who underwent supramarginal resection of a cerebral metastasis by awake surgery with intraoperative cortical and subcortical stimulation, MEPs, and SSEPs. Supramarginal resection was achieved by circumferential stripping of the metastasis and additional removal of approximately 3 mm of the surrounding tissue. Pre- and postsurgical neurological status was assessed by the NIH Stroke Scale. Permanent deficits were defined by persistence after 3-month observation time.

Results

Supramarginal resection of cerebral metastases in eloquent brain areas was performed in 34 patients with a mean age of 60 years (range, 33–83 years). Five out of 34 patients (14.7 %) had a new transient postoperative neurological deficit, which improved within a few days due to supplementary motor area (SMA) syndrome. Five out of 34 patients (14.7 %) developed a local in-brain progression and nine patients (26.4 %) a distant in-brain progression.

Conclusions

Supramarginal resection of cerebral metastases in eloquent locations is feasible and safe. Safety might be increased by intraoperative neuromonitoring. The better outcome in the present series may be entirely based on other predictors than extend of surgical resection and not necessarily on the surgical technique applied. However, supramarginal resection was safe and apparently did not lead to worse results than regular surgical techniques. Prospective, controlled, and randomized studies are mandatory to determine the possible benefit of supramarginal resection on local tumor control and overall outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, Kenjyo M, Oya N, Hirota S, Shioura H, Kunieda E, Inomata T, Hayakawa K, Katoh N, Kobashi G (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA 295:2483–2491

    Article  CAS  PubMed  Google Scholar 

  2. Bannur U, Rajshekhar V (2000) Post operative supplementary motor area syndrome: clinical features and outcome. Br J Neurosurg 14:204–210

    Article  CAS  PubMed  Google Scholar 

  3. Baumert BG, Rutten I, Dehing-Oberije C, Twijnstra A, Dirx MJ, Debougnoux-Huppertz RM, Lambin P, Kubat B (2006) A pathology-based substrate for target definition in radiosurgery of brain metastases. Int J Radiat Oncol Biol Phys 66:187–194

    Article  PubMed  Google Scholar 

  4. Berghoff AS, Rajky O, Winkler F, Bartsch R, Furtner J, Hainfellner JA, Goodman SL, Weller M, Schittenhelm J, Preusser M (2013) Invasion patterns in brain metastases of solid cancers. Neuro-Oncology 15:1664–1672

    Article  PubMed Central  PubMed  Google Scholar 

  5. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, Arbuckle RB, Swint JM, Shiu AS, Maor MH, Meyers CA (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10:1037–1044

    Article  PubMed  Google Scholar 

  6. Etminan N, Beseoglu K, Heiroth HJ, Turowski B, Steiger HJ, Hanggi D (2013) Early perfusion computerized tomography imaging as a radiographic surrogate for delayed cerebral ischemia and functional outcome after subarachnoid hemorrhage. Stroke 44:1260–1266

    Article  PubMed  Google Scholar 

  7. Fontaine D, Capelle L, Duffau H (2002) Somatotopy of the supplementary motor area: evidence from correlation of the extent of surgical resection with the clinical patterns of deficit. Neurosurgery 50:297–303

    PubMed  Google Scholar 

  8. Kamp MA, Dibue M, Niemann L, Reichelt DC, Felsberg J, Steiger HJ, Szelenyi A, Rapp M, Sabel M (2012) Proof of principle: supramarginal resection of cerebral metastases in eloquent brain areas. Acta Neurochir (Wien) 154:1981–1986

    Article  Google Scholar 

  9. Kamp MA, Grosser P, Felsberg J, Slotty PJ, Steiger HJ, Reifenberger G, Sabel M (2012) 5-aminolevulinic acid (5-ALA)-induced fluorescence in intracerebral metastases: a retrospective study. Acta Neurochir (Wien) 154:223–228

    Article  Google Scholar 

  10. Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141

    Article  PubMed Central  PubMed  Google Scholar 

  11. Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O’Day SJ, Essner R, Zelman V, Yu C, Luxton G, Apuzzo ML (1999) Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 44:59–64

    Article  CAS  PubMed  Google Scholar 

  12. Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW (2008) Microsurgery plus whole-brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neuro-Oncol 87:299–307

    Article  Google Scholar 

  13. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, Markesbery WR, Foon KA, Young B (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA 280:1485–1489

    Article  CAS  PubMed  Google Scholar 

  14. Russell SM, Kelly PJ (2003) Incidence and clinical evolution of postoperative deficits after volumetric stereotactic resection of glial neoplasms involving the supplementary motor area. Neurosurgery 52:506–516

    Article  PubMed  Google Scholar 

  15. Sheehan JP, Sun MH, Kondziolka D, Flickinger J, Lunsford LD (2003) Radiosurgery in patients with renal cell carcinoma metastasis to the brain: long-term outcomes and prognostic factors influencing survival and local tumor control. J Neurosurg 98:342–349

    Article  PubMed  Google Scholar 

  16. Ulu MO, Tanriover N, Ozlen F, Sanus GZ, Tanriverdi T, Ozkara C, Uzan M (2008) Surgical treatment of lesions involving the supplementary motor area: clinical results of 12 patients. Turk Neurosurg 18:286–293

    PubMed  Google Scholar 

  17. Yoo H, Kim YZ, Nam BH, Shin SH, Yang HS, Lee JS, Zo JI, Lee SH (2009) Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg 110:730–736

    Article  PubMed  Google Scholar 

  18. Zentner J, Hufnagel A, Pechstein U, Wolf HK, Schramm J (1996) Functional results after resective procedures involving the supplementary motor area. J Neurosurg 85:542–549

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Funding

The present study was not funded.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcel A. Kamp.

Additional information

Comment

This is a single-center, retrospective study of 34 patients who underwent MRI-verified supramarginal resection of a single cerebral metastasis in an eloquent area by awake surgery with intraoperative monitoring. The study demonstrates that supramarginal resection was feasible as no permanent postoperative neurological deficits were observed. Furthermore, supramarginal resection achieved better tumor control.

The strengths of this study, albeit a retrospective one, are the clear definitions of eloquence, inclusion criteria and exclusion criteria, the very careful follow-up with outpatient clinic and MRI every 3 months, and that the limitations of the study are identified and clearly stated. Furthermore, the analysis is careful and the discussion is precise and pertinent. The results are not “over-sold”, although the supramarginal resection resulted in a very low local in-brain progression.

There are some weaknesses, such as the retrospective design and that proof of concept has been previously demonstrated for metastases in non-eloquent areas. The study group is selected. Six patients (15 %) were excluded from the study as the intraoperative monitoring suggested further resection would result in neurological deficits. Furthermore, due to the strict inclusion and exclusion criteria, a number of patients with metastases in eloquent regions must have been excluded. We are not given information about them. Lastly, although the neurological outcome was scored using standardized methods, it was not scored by an independent operator.

There are also some unanswered questions. One inclusion criterion is a complete set of pre- and postoperative MRI. How many were excluded due to lack of postoperative MRI? There is clearly a selection bias unless every single patient has a postoperative MRI and not at the surgeon’s discretion. Surgeon-independent confirmation of a supramarginal resection was not performed, nor quantification of supramarginal resection beyond tumor resection. What substantiates the notion that supramarginal resection is different from your standard MRI-verified complete extirpation?

Torstein Meling

Oslo, Norway

Marcel A. Kamp and Marion Rapp contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kamp, M.A., Rapp, M., Slotty, P.J. et al. Incidence of local in-brain progression after supramarginal resection of cerebral metastases. Acta Neurochir 157, 905–911 (2015). https://doi.org/10.1007/s00701-015-2405-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00701-015-2405-9

Keywords

Navigation